Search Results - David Matten

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials. by Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, Rebecca T van Dorsten, Amanda S Woodward Davis, Nicolas Beaume, David Matten, Bronwen Lambson, Tandile Modise, Prudence Kgagudi, Talita York, Dylan H Westfall, Elena E Giorgi, Bette Korber, Colin Anthony, Rutendo E Mapengo, Valerie Bekker, Elizabeth Domin, Amanda Eaton, Wenjie Deng, Allan DeCamp, Yunda Huang, Peter B Gilbert, Asanda Gwashu-Nyangiwe, Ruwayhida Thebus, Nonkululeko Ndabambi, Dieter Mielke, Nyaradzo Mgodi, Shelly Karuna, Srilatha Edupuganti, Michael S Seaman, Lawrence Corey, Myron S Cohen, John Hural, M Juliana McElrath, James I Mullins, David Montefiori, Penny L Moore, Carolyn Williamson, Lynn Morris

    Published in PLoS Pathogens (2023-06-01)
    Get full text
    Article


  2. 2

    Bayesian estimation of HIV acquisition dates for prevention trials by Raabya Rossenkhan, Elena E. Giorgi, Danica Shao, James Ludwig, Phillip Labuschagne, Craig A. Magaret, Thumbi Ndung'u, Daniel Muema, Kamini Gounder, Krista L. Dong, Bruce D. Walker, Morgane Rolland, Merlin L. Robb, Leigh Anne Eller, Fredrick Sawe, Sorachai Nitayaphan, Eduard Grebe, Michael P. Busch, Kevin P. Delaney, Shelley Facente, Lindsay N. Carpp, Allan C. deCamp, Yunda Huang, Bette Korber, Michal Juraska, Erika Rudnicki, Ewelina Kosmider, Daniel B. Reeves, Bryan T. Mayer, John Hural, Wenjie Deng, Dylan H. Westfall, Anna Yssel, David Matten, Tanmoy Bhattacharya, Lawrence Corey, Peter B. Gilbert, Carolyn Williamson, James I. Mullins, Paul T. Edlefsen

    Published in mBio (2025-10-01)
    Get full text
    Article


Search Tools: